Portfolio Overview
Ownership & Control Structure
What Companies Does Andrew Huberman Own?
Andrew Huberman co-owns Scicomm Media, the commercial media company that produces Huberman Lab. He also has documented equity involvement in Mateina and David, two consumer businesses backed alongside other investors. We distinguish the media company he helped establish from the brands that advertise on his programs: sponsorship or compensated scientific advice does not establish ownership, and a commercial relationship with a business should not automatically be counted as a personal investment or a controlled subsidiary.
Mateina’s January 2024 US launch announcement identified Tiny and Huberman as the investors behind their jointly majority-owned beverage business. Tiny held its interest through Tiny’s first investment fund. That confirms Huberman’s equity participation, without identifying his individual percentage or prove that he independently controls the company. Mateina’s original founders remained involved, and his collaboration on a sugar-free product adds a commercial role without making him the sole founder or owner of the Canadian beverage brand.
David named Huberman as a participant in its $10 million seed financing in August 2024. The round was led by co-founder Peter Rahal and also included Valor Siren Ventures and Peter Attia. The announced amount belonged to the financing round as a whole, not to Huberman’s personal contribution. His interest is an investor position in a separate nutrition business, rather than ownership of every company associated with the other participants or their wider investment organizations.
Hims & Hers Health added a different relationship in November 2026: a board seat, paid advisory work, advertising purchased from Scicomm and 19,301 director restricted stock units. Those awards carry vesting conditions and are distinct from an unrestricted controlling stake. Scicomm’s own investments in certain sponsors also remain company-level interests unless individual attribution is disclosed. Huberman’s current business picture therefore combines shared media ownership, named consumer equity positions and contractual compensation, while Stanford remains his academic employer rather than a business he personally owns.
Portfolio Analysis
Huberman’s portfolio joins a media platform with consumer products marketed to people interested in health and performance. Scicomm Media supplies the audience-facing business, Mateina provides beverage exposure and David adds nutrition products. We see a coherent commercial theme rather than broad independence between assets. A change in audience trust could influence the media operation and the effectiveness of product associations together, even though the companies have different founders, cost structures and day-to-day management responsibilities within their own businesses.
The Hims advertising agreement adds a visible counterparty concentration inside Scicomm. Its $5 million annual company fee is meaningful in absolute terms, but the public filing does not disclose Scicomm’s total revenue, so a precise concentration percentage cannot be calculated. The agreement also creates a connection between an advertiser, Huberman’s board role and his advisory work. Those overlapping relationships may deepen commercial collaboration while making it especially important that contractual income, investment returns and corporate governance duties are not conflated.
Mateina and David diversify the way money might be earned, because their value depends on product businesses rather than only advertising demand. They nevertheless introduce inventory, manufacturing and distribution exposure that Scicomm does not bear in the same form. A successful campaign can increase initial purchases without ensuring attractive product margins or lasting demand. The portfolio’s apparent fit therefore should be evaluated against the operating discipline of the underlying businesses, rather than assuming that a shared customer interest guarantees complementary financial performance.
Stanford employment remains outside this ownership mix, while unnamed sponsor investments held by Scicomm should not be reclassified as direct personal holdings. The ownership announcements do not provide a full allocation of Andrew Huberman’s wealth among these interests. His strongest documented control position is shared ownership of the media business; the consumer investments have other owners and undisclosed personal percentages. This makes the financial picture less like a wholly owned wellness conglomerate and more like a media-centered collection of operating and investment relationships with several distinct economic claims.
Business Profile
Scicomm Media converts Huberman’s science communication into a commercial production business. Its role is separate from his research and teaching at Stanford, as the program’s disclosures explicitly state. Advertising, subscriptions and related media activity can support a recurring audience relationship, but production costs and partner arrangements affect the amount retained. We see the central business asset as an organized media operation with distribution and commercial relationships, rather than treating an academic laboratory and a podcast as interchangeable legal or financial entities.
The November 2026 Hims arrangements make part of that model unusually visible. The healthcare company agreed to pay Scicomm $5 million annually for podcast advertising for up to three years, subject to the agreement’s termination provisions. That is revenue contracted with a company, not Huberman’s personal salary. Producing and delivering advertising involves an operating organization, and the filing’s separate attribution of his economic interest reinforces the need to distinguish company receipts from the amount ultimately available to him after expenses and distributions.
Mateina adds a product business with different cash requirements. Its 2024 announcement described a low-sugar and organic yerba mate proposition, including a sugar-free version co-developed with Huberman for the US. A beverage must be produced, stocked and distributed before media attention can produce repeat retail purchases. Tiny’s investment partnership and Mateina’s founders supply capabilities beyond the public association. The commercial opportunity depends on product demand and execution, not on applying the economics of an advertising slot directly to sales of cans.
David’s seed financing supports another physical-product model, initially focused on high-protein foods. Its August 2024 release named Huberman as an investor rather than the business’s founder or chief executive. Both consumer investments can benefit from a relevant audience, yet each requires its own operating management and capital. The resulting business mix connects science-oriented communication with consumer products while preserving a fundamental distinction between earning fees for media services and participating in the longer-term residual value of a privately held company.
Controlled Businesses
Companies Currently Owned or Controlled
- Scicomm Media
| Company | Relationship | Role | Since |
|---|---|---|---|
| Scicomm Media | Shared control | Co-founder | 2021 |
Control & Capital Allocation Analysis
Scicomm Media is the principal company Huberman is documented to co-own. The Hims filing and his program’s disclosures independently confirm that relationship. Shared ownership supports substantial involvement without establishing unilateral voting control or a published percentage. We avoid deriving a capitalization table from the $2.1 million annual interest attributed to him in one advertising agreement: that attribution describes an economic relationship in a specific contract and is not expressly a disclosure of his percentage ownership of every asset or activity inside Scicomm.
Mateina’s ownership language requires similar care. Tiny and Huberman jointly backed the majority-owned business described in January 2024, with Tiny’s interest held through a fund. A combined majority does not reveal how votes or board rights are divided between those investors and the original founders. His product-development contribution establishes involvement, while the partnership structure limits any claim that he alone can approve a sale, direct all company spending or determine the terms of later financing without other stakeholders participating.
David’s funding announcement identifies Huberman as one investor within a round led by Peter Rahal. That provides evidence of equity exposure but no governing authority comparable to an executive or controlling shareholder. Scientific credibility and audience access can help a young brand, yet the founders and board remain separate from the investor’s promotional value. His role should therefore be assessed through the actual rights disclosed, instead of treating a recognizable participant in a financing controls the company or its entire product strategy.
The November 2026 Hims appointment creates a board responsibility at a public healthcare business, not ownership control over it. The accompanying advisory and advertising relationships are commercial contracts, while the director stock awards vest according to their terms. Those categories can coexist but carry different duties and risks. Huberman’s academic affiliation adds another institutional boundary: Scicomm’s programs are explicitly separate from Stanford’s official positions, preventing a commercial media relationship from being represented as ownership of, or institutional endorsement by, the university.
Minority Stakes, Investments & Brands
Minority Ownership Stakes
- Mateina
- David
| Company | Role | Since | Status |
|---|---|---|---|
| Mateina | Co-owner | 2024 | Active |
| David | Investor | 2024 | Active |
Businesses Andrew Huberman Has Invested In
| Company | Year | Amount or Stake | Status |
|---|---|---|---|
| Hims & Hers Health | 2026 | 19,301 unvested RSUs | Vesting |
Minority-Stake & Investment Analysis
Mateina’s January 2024 announcement tied Huberman’s investment participation to a tangible product contribution: a sugar-free yerba mate beverage developed for the US market. Partnering with Tiny and the original founders combines audience access with financial and operating resources. We would judge the investment by whether that collaboration improves repeat purchasing and distribution economics, rather than by the publicity attached to the launch. The personal entry price and stake were not published, so no return multiple can responsibly be calculated from the announcement alone.
David’s $10 million seed round in August 2024 provides another example of a named investment without a disclosed personal check. Huberman participated with Valor Siren Ventures, Rahal and Attia, with funding directed toward nutrition products and team development. Seed-stage equity can offer exposure to later growth, but its payoff depends on subsequent financing and business execution. An investor’s percentage may decline when new money enters even if the company’s overall value rises or its products reach a wider market.
Scicomm’s disclosures say that the company itself has investments in some program sponsors. That adds another possible layer of exposure, but it does not identify an attributable personal amount for each sponsor. AG1, Eight Sleep, Function Health, Momentous, Reveri and WHOOP are named as compensated advisory relationships. Compensation can take different forms, and the disclosure alone is insufficient to assign a current direct equity stake in each. The investment list should reflect named ownership evidence rather than treating every commercial partner as another verified personal holding.
Hims & Hers Health director RSUs represent compensation with vesting requirements rather than a cash investment made on the open market. Their economic risk differs from the cash fee under the advisory agreement and from Scicomm’s advertising revenue. Huberman’s opportunity set therefore includes several claims with different timing: private shares, media-company earnings, contractual fees and conditional equity awards. Evaluating those separately reveals the actual capital and execution exposure, instead of collapsing them into a single undifferentiated valuation of a wellness empire based on his public visibility.
Transactions, Acquisitions & Exits
Deal Activity Timeline
Acquisitions Led or Financed
| Acquisition | Year | Role | Outcome |
|---|---|---|---|
| Mateina | 2024 | Co-investor with Tiny | Completed |
Transaction & Exit Analysis
Huberman’s disclosed ownership record contains investment entries more clearly than completed company exits. Mateina’s January 2024 announcement describes participation alongside Tiny and a US product launch, not a disposal of his interest. David’s August 2024 financing likewise establishes entry as an investor. We therefore do not assign him a realized return merely because either company raised money, expanded availability or attracted press coverage. A financing or launch can change prospects while leaving the investor’s cash tied up in privately held shares.
The November 2026 Hims agreements are service contracts, not a purchase of Scicomm Media. The advertiser agreed to buy podcast placements, while Huberman separately accepted advisory work and joined the board. Those arrangements may generate cash over time, but these arrangements do not indicate a Hims acquisition of the media company or that its co-owners sold their equity. Confusing a commercial contract with a corporate acquisition would overstate both the scale of his exit history and the ownership rights transferred to the advertiser through the arrangement.
Private consumer holdings have several possible realization routes, including a strategic acquisition or a permitted secondary share sale. Whether Huberman could use those routes depends on agreements that were not disclosed in the Mateina and David announcements. Other shareholders may have preferences or transfer rights that influence timing and proceeds. A successful operating business can consequently remain illiquid to an individual investor, and a favorable company valuation does not ensure that the same amount can be converted into personal cash immediately or without transaction costs.
Scicomm Media’s continuing production activity and current disclosures support retained ownership instead of a concluded disposal. Director equity awards at Hims also require vesting before they become equivalent to unrestricted marketable shares. Huberman’s liquidity picture should therefore be analyzed through fees actually earned, distributions received and any specifically documented securities transactions, rather than manufacturing an exit schedule from the commercial growth of his partners. The transaction record supports named investments and contracts, while realized investor proceeds remain a separate question requiring its own evidence.
Wealth, Income & Financial Trends
Net Worth & Sources of Wealth
Net Worth
Apr-2026Annual Income
Jul-2026Wealth & Income Analysis
Huberman’s $30 million wealth figure appeared at Celebrity Net Worth in 2026, without supplying a complete personal balance sheet or market valuation of Scicomm. That makes it a weak external wealth measure rather than a verified total of liquid assets. We give greater analytical weight to the specific contractual terms disclosed in November, while keeping them separate from accumulated net worth. Forbes’ July 2026 ranking separately attributed $18 million in pretax podcast earnings to Huberman and his operation over June 2025 to June 2026, before representation fees.
Hims agreed to pay Huberman $3.5 million annually for two years of scientific and brand-marketing advisory services. This forward annual fee differs from the $18 million podcast figure, which covers an earlier reporting window. Optional short-form advertising work could add up to $1 million per year, but optional compensation is not guaranteed income. A $50,000 annual board retainer and $250,000 annual equity award are further separate categories, and fees beginning late in 2026 do not represent cash received over that entire calendar year.
Scicomm’s agreement calls for $5 million in annual podcast advertising payments over a maximum three-year term, subject to termination rights. The filing attributes approximately $2.1 million of annual economic interest in that agreement to Huberman. That amount is neither an additional $5 million personal salary nor proof that the complete contract value becomes profit. Production expenses, company obligations and distributions affect what is retained, while an agreement that can end early should not be valued as certain cash receipts across its maximum stated duration.
Mateina and David add private equity interests without published personal valuations. Their financing amounts cannot establish his stake values, and unrealized business growth is different from sale proceeds. The $30 million publication therefore remains uncertain even alongside clearer evidence of current earning power. His reported wealth should not be constructed by adding sponsor company valuations, a university research budget or the entire revenue of Scicomm to personal fees, because those figures belong to different legal entities and economic claims rather than a single individual balance sheet.
Portfolio Development Over Time
Business Ownership Timeline
Business Trajectory Analysis
Huberman’s 2021 media launch created a commercial organization alongside his academic work. Scicomm Media made production and sponsorship relationships part of a company rather than treating every episode as an isolated appearance. We see that organizational step as the foundation for later investment opportunities: a recurring audience can create bargaining power with product businesses, but turning attention into durable value requires dependable programming and a clear distinction between commercial activity and the academic institution with which the presenter is associated.
The January 2024 Mateina announcement connected that audience to product development and ownership. Its US debut included a sugar-free beverage created with Huberman, showing involvement beyond an ordinary advertising read. David’s seed round later that year added a second named consumer investment in nutrition. Both milestones broadened his exposure while introducing the operating realities of physical products, including production and distribution requirements that are not solved simply by publishing more content or attracting additional program sponsors to the media business.
The 2026 publication of Protocols expanded his commercial communication into books, while November brought a board and advisory relationship with Hims. The separate Scicomm advertising agreement formalized a sizable company revenue stream with stated termination rights. That combination deepens the connection between media reach and consumer healthcare. It also increases the value of clear disclosures because an audience may encounter the same company through programming, advertising and the presenter’s governance role, each of which has different implications for trust and economic incentives.
Further progress requires maintaining the strength of the media franchise while allowing product companies to succeed through their own operations. For Mateina and David, recurring demand is more useful evidence than the initial launch response. For Scicomm, retaining audience engagement and balancing advertiser relationships determine business durability. Huberman’s contracts now provide clearer evidence of earning capacity, but their existence does not establish a saleable valuation for his private holdings or remove the need to assess vesting, counterparty concentration and the distinction between company revenue and personal wealth.
Ownership Misconceptions Explained
Huberman owns Stanford’s research laboratory as a private company.
His Stanford appointment is an academic position within the university. The program’s own disclosures separate Scicomm Media’s commercial production from those institutional duties. The use of Huberman Lab as a media name does not transfer university ownership, research assets or institutional authority to its presenter.
Hims bought Scicomm Media in November 2026.
The disclosed transaction was an advertising-services agreement with Scicomm, accompanied by a separate personal advisory contract and a board appointment for Huberman. Those relationships did not establish an acquisition of the media company or a sale of the co-owners’ shares to the healthcare business.
Every annual advertising dollar belongs personally to Huberman.
The $5 million annual Hims advertising fee is paid to Scicomm Media. The filing separately attributes approximately $2.1 million of annual economic interest to Huberman. Company expenses, contractual duration and distributions still matter, so gross business receipts cannot be described as his unrestricted take-home pay.
Director stock awards are equivalent to an unrestricted company stake.
Restricted stock units carry vesting conditions and represent compensation rights under their award terms. They differ from already unrestricted shares and do not create controlling authority. Huberman’s board appointment, service fees and conditional equity exposure therefore remain separate features of the Hims relationship.
Frequently Asked Questions
What business does Andrew Huberman co-own?
Huberman co-founded and co-owns Scicomm Media, the commercial producer of Huberman Lab. The company’s ownership was also confirmed in Hims’ November 2026 filing. It operates separately from his academic teaching and research, so Stanford is not part of his personal company portfolio.
Does Andrew Huberman own Mateina?
A January 2024 announcement identified Tiny and Huberman as the backers of their jointly majority-owned Mateina beverage business. His individual percentage and independent control were not disclosed. The relationship confirms equity involvement alongside other owners, rather than sole ownership of the company or its original founding.
Did Huberman invest $10 million in David?
David announced a $10 million seed round in August 2024 and named Huberman among several participating investors. Peter Rahal led the financing. The release did not identify Huberman’s personal contribution, so the total round size cannot be attributed to him as an individual investment check.
How much does Hims pay Andrew Huberman?
The November 2026 disclosure states a $3.5 million annual personal advisory fee for two years. Separate arrangements include optional short-form work and advertising purchased from Scicomm Media. The company’s $5 million annual advertising fee is not the same as Huberman’s personal salary or guaranteed take-home income.
Does Huberman own every company sponsoring his program?
His commercial disclosures in November 2026 identify compensated advisory relationships and state that Scicomm holds investments in some sponsors. They do not establish a direct personal equity stake in every advertiser. Named investments, advisory fees, corporate interests and conditional stock awards must be distinguished.
